1. Home
  2. AZTA vs CERT Comparison

AZTA vs CERT Comparison

Compare AZTA & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • CERT
  • Stock Information
  • Founded
  • AZTA 1978
  • CERT 2008
  • Country
  • AZTA United States
  • CERT United States
  • Employees
  • AZTA N/A
  • CERT N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • CERT Retail: Computer Software & Peripheral Equipment
  • Sector
  • AZTA Technology
  • CERT Technology
  • Exchange
  • AZTA Nasdaq
  • CERT Nasdaq
  • Market Cap
  • AZTA 2.4B
  • CERT 2.3B
  • IPO Year
  • AZTA 1995
  • CERT 2020
  • Fundamental
  • Price
  • AZTA $44.75
  • CERT $13.17
  • Analyst Decision
  • AZTA Buy
  • CERT Buy
  • Analyst Count
  • AZTA 4
  • CERT 7
  • Target Price
  • AZTA $58.75
  • CERT $15.92
  • AVG Volume (30 Days)
  • AZTA 546.3K
  • CERT 1.4M
  • Earning Date
  • AZTA 02-05-2025
  • CERT 02-26-2025
  • Dividend Yield
  • AZTA N/A
  • CERT N/A
  • EPS Growth
  • AZTA N/A
  • CERT N/A
  • EPS
  • AZTA N/A
  • CERT N/A
  • Revenue
  • AZTA $662,108,000.00
  • CERT $372,797,000.00
  • Revenue This Year
  • AZTA N/A
  • CERT $10.48
  • Revenue Next Year
  • AZTA $6.29
  • CERT $9.94
  • P/E Ratio
  • AZTA N/A
  • CERT N/A
  • Revenue Growth
  • AZTA 5.36
  • CERT 5.62
  • 52 Week Low
  • AZTA $38.82
  • CERT $9.41
  • 52 Week High
  • AZTA $67.77
  • CERT $19.87
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 31.74
  • CERT 48.29
  • Support Level
  • AZTA $43.93
  • CERT $13.54
  • Resistance Level
  • AZTA $46.10
  • CERT $15.69
  • Average True Range (ATR)
  • AZTA 2.60
  • CERT 0.70
  • MACD
  • AZTA -0.77
  • CERT -0.16
  • Stochastic Oscillator
  • AZTA 7.00
  • CERT 2.70

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: